Related Experiment Video
Updated: Jun 22, 2026

Production of Double-stranded DNA Ministrings
Published on: February 29, 2016
Use of minicircle plasmids for gene therapy
Peter Mayrhofer1, Martin Schleef, Wolfgang Jechlinger
1Mayrhofer & Jechlinger OEG, Vienna, Austria.
Abstract:
A large number of cancer gene therapy clinical trials are currently being performed that are attempting to evaluate novel approaches to eliminate tumor cells by the introduction of genetic material into patients. One of the most important objectives in gene therapy is the development of highly safe and efficient vector systems for gene transfer in eukaryotic cells. Currently, viral and nonviral vector systems are used, both having their advantages and limitations. Minicircles are novel supercoiled minimal expression cassettes, derived from conventional plasmid DNA by site-specific recombination in vivo in Escherichia coli for the use in nonviral gene therapy and vaccination. Minicircle DNA lacks the bacterial backbone sequence consisting of an antibiotic resistance gene, an origin of replication, and inflammatory sequences intrinsic to bacterial DNA. In addition to their improved safety profile, minicircles have been shown to greatly increase the efficiency oftransgene expression in various in vitro and in vivo studies. In this chapter, we describe the production, purification, and application of minicircle DNA and discuss the rationale of the improved gene transfer efficiencies compared to conventional plasmid DNA.
Insights
Minicircle DNA offers a safer and more effective nonviral gene therapy vector by removing bacterial DNA. This enhances transgene expression for improved cancer gene therapy and vaccination applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Gene therapy aims to eliminate tumor cells by introducing genetic material.
- Viral and nonviral vectors are used for gene transfer, each with pros and cons.
- Minicircles are novel DNA vectors derived from plasmids for nonviral gene therapy.
Purpose of the Study:
- To describe the production, purification, and application of minicircle DNA.
- To discuss the rationale behind minicircle DNA's enhanced gene transfer efficiency.
- To highlight minicircles as improved vectors for nonviral gene therapy and vaccination.
Main Methods:
- Minicircle DNA is produced via site-specific recombination in Escherichia coli.
- Purification methods isolate minicircle DNA from bacterial components.
- Production and application protocols for minicircle DNA are detailed.
Main Results:
- Minicircle DNA lacks bacterial backbone sequences, improving safety.
- Minicircles demonstrate significantly enhanced transgene expression efficiency.
- Studies show improved in vitro and in vivo gene transfer with minicircles compared to plasmids.
Conclusions:
- Minicircle DNA represents a superior nonviral vector for gene therapy.
- The absence of bacterial DNA enhances safety and transgene expression.
- Minicircles hold significant promise for advancing cancer gene therapy and vaccination strategies.
More Related Videos
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
07:40Gene Transfection toward Spheroid Cells on Micropatterned Culture Plates for Genetically-modified Cell Transplantation
Published on: July 31, 2015
Related Concept Videos
Gene Therapy
Gene Therapy
Microorganisms in Medicine and Therapeutics
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...